Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab.

Failing, Jarrett J; Ho, Thanh P; Yadav, Siddhartha; Majithia, Neil; Riaz, Irbaz Bin; Shin, John Y; Schenk, Erin L; Xie, Hao

Failing, Jarrett J; Ho, Thanh P; Yadav, Siddhartha; Majithia, Neil; Riaz, Irbaz Bin; Shin, John Y; Schenk, Erin L; Xie, Hao.

Afiliação

Failing JJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Ho TP; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Yadav S; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Majithia N; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Riaz IB; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Shin JY; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Schenk EL; Division of Medical Oncology, Department of Internal Medicine, University of Colorado Cancer Center, Aurora, CO.
Xie H; Division of Medical Oncology, Mayo Clinic, Rochester, MN.

JCO Oncol Pract ; 16(7): e573-e580, 2020 07.

Article em En | MEDLINE | ID: mdl-32048920

Assuntos

Vacinas contra Influenza; Neoplasias; Anticorpos Monoclonais Humanizados/efeitos adversos; Humanos; Vacinas contra Influenza/efeitos adversos; Neoplasias/tratamento farmacológico; Estudos Retrospectivos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Mongólia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google